Non-invasive Cancer Diagnosis Market Report

China Non-invasive Cancer Diagnosis Industry Market Research Report 2023-2029

  • POSTDATE：Aug 27, 2023
  • PAGES：229
  • REPORT CODE：GMM1760955
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Non-invasive Cancer Diagnosis industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • BioView Inc

    • Gen-Probe Inc

    • A&G Pharmaceutical

    • LabCorp

    • Digene Corporation

    • Affymetrix Inc

    • Quest Diagnostics Inc

    • Precision Therapeutics

    By Type:

    • Others

    • Clinical Chemistry

    • Molecular Diagnostics

    • Immunochemistry/Immunoassay

    By Application:

    • Lung Cancer

    • Solid Tumors

    • Blood Cancer

    • Breast Cancer

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Non-invasive Cancer Diagnosis Market Overview 2018-2029

    • 1.1 China Non-invasive Cancer Diagnosis Industry Development Overview

    • 1.2 China Non-invasive Cancer Diagnosis Industry Development History

    • 1.3 China Non-invasive Cancer Diagnosis Industry Market Size (2018-2029)

    • 1.4 China Non-invasive Cancer Diagnosis Market Analysis by Type from Production Side

      • 1.4.1 China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.2 China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Clinical Chemistry (2018-2029)

      • 1.4.3 China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Molecular Diagnostics (2018-2029)

      • 1.4.4 China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Immunochemistry/Immunoassay (2018-2029)

    • 1.5 China Non-invasive Cancer Diagnosis Market Analysis by Application from Consumption End

      • 1.5.1 China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.2 China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Solid Tumors (2018-2029)

      • 1.5.3 China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

      • 1.5.4 China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.5 China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Non-invasive Cancer Diagnosis Market Analysis by Region

      • 1.6.1 North China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    Chapter 2 China Non-invasive Cancer Diagnosis Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Non-invasive Cancer Diagnosis Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Non-invasive Cancer Diagnosis Market Status and Competition Analysis in 2023

      • 2.2.3 China Non-invasive Cancer Diagnosis Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Non-invasive Cancer Diagnosis Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Non-invasive Cancer Diagnosis Industry Development

    Chapter 3 Non-invasive Cancer DiagnosisIndustry Chain Analysis

    • 3.1 Non-invasive Cancer Diagnosis Industry Chain

    • 3.2 Non-invasive Cancer Diagnosis Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Non-invasive Cancer Diagnosis Market

    • 3.3 Non-invasive Cancer Diagnosis Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Non-invasive Cancer Diagnosis Market

    Chapter 4 China Non-invasive Cancer Diagnosis Market, by Type

    • 4.1 China Non-invasive Cancer Diagnosis Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Non-invasive Cancer Diagnosis Total Production Volume and Growth Rate from Production Side

    • 4.5 China Non-invasive Cancer Diagnosis Production Volume and Growth Rate, by Type

      • 4.5.1 China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Others

      • 4.5.2 China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Clinical Chemistry

      • 4.5.3 China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Molecular Diagnostics

      • 4.5.4 China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Immunochemistry/Immunoassay

    Chapter 5 China Non-invasive Cancer Diagnosis Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Non-invasive Cancer Diagnosis Total Market Size and Growth Rate from Consumption End

    • 5.5 China Non-invasive Cancer Diagnosis Market Size and Growth Rate, by Application

      • 5.5.1 China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Lung Cancer

      • 5.5.2 China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Solid Tumors

      • 5.5.3 China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Blood Cancer

      • 5.5.4 China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Breast Cancer

      • 5.5.5 China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Others

    Chapter 6 China Non-invasive Cancer Diagnosis Market, by Region

    • 6.1 China Non-invasive Cancer Diagnosis Production Volume and Production Value, by Region

    • 6.2 China Non-invasive Cancer Diagnosis Sales Volume and Sales Value, by Region

    Chapter 7 North China Non-invasive Cancer Diagnosis Market Analysis

    • 7.1 North China Non-invasive Cancer Diagnosis Market, by Type

    • 7.2 North China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 8 Central China Non-invasive Cancer Diagnosis Market Analysis

    • 8.1 Central China Non-invasive Cancer Diagnosis Market, by Type

    • 8.2 Central China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 9 South China Non-invasive Cancer Diagnosis Market Analysis

    • 9.1 South China Non-invasive Cancer Diagnosis Market, by Type

    • 9.2 South China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 10 East China Non-invasive Cancer Diagnosis Market Analysis

    • 10.1 East China Non-invasive Cancer Diagnosis Market, by Type

    • 10.2 East China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 11 Northeast China Non-invasive Cancer Diagnosis Market Analysis

    • 11.1 Northeast China Non-invasive Cancer Diagnosis Market, by Type

    • 11.2 Northeast China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 12 Southwest China Non-invasive Cancer Diagnosis Market Analysis

    • 12.1 Southwest China Non-invasive Cancer Diagnosis Market, by Type

    • 12.2 Southwest China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 13 Northwest China Non-invasive Cancer Diagnosis Market Analysis

    • 13.1 Northwest China Non-invasive Cancer Diagnosis Market, by Type

    • 13.2 Northwest China Non-invasive Cancer Diagnosis Market, by Application

    Chapter 14 Company Profiles

      • 14.1 BioView Inc

        • 14.1.1 BioView Inc Company Profile

        • 14.1.2 BioView Inc Non-invasive Cancer Diagnosis Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Gen-Probe Inc

        • 14.2.1 Gen-Probe Inc Company Profile

        • 14.2.2 Gen-Probe Inc Non-invasive Cancer Diagnosis Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 A&G Pharmaceutical

        • 14.3.1 A&G Pharmaceutical Company Profile

        • 14.3.2 A&G Pharmaceutical Non-invasive Cancer Diagnosis Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 LabCorp

        • 14.4.1 LabCorp Company Profile

        • 14.4.2 LabCorp Non-invasive Cancer Diagnosis Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Digene Corporation

        • 14.5.1 Digene Corporation Company Profile

        • 14.5.2 Digene Corporation Non-invasive Cancer Diagnosis Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Affymetrix Inc

        • 14.6.1 Affymetrix Inc Company Profile

        • 14.6.2 Affymetrix Inc Non-invasive Cancer Diagnosis Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Quest Diagnostics Inc

        • 14.7.1 Quest Diagnostics Inc Company Profile

        • 14.7.2 Quest Diagnostics Inc Non-invasive Cancer Diagnosis Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Precision Therapeutics

        • 14.8.1 Precision Therapeutics Company Profile

        • 14.8.2 Precision Therapeutics Non-invasive Cancer Diagnosis Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Non-invasive Cancer Diagnosis Industry Research Conclusions

    • 15.2 Non-invasive Cancer Diagnosis Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Non-invasive Cancer Diagnosis Industry Market Size (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Clinical Chemistry (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Molecular Diagnostics (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Production Volume, Production Value and Growth Rate of Immunochemistry/Immunoassay (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Solid Tumors (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Blood Cancer (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Non-invasive Cancer Diagnosis Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure Central China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure South China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure East China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Non-invasive Cancer Diagnosis Market Size and Growth Rate from 2018-2029

    • Figure Non-invasive Cancer Diagnosis Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Non-invasive Cancer Diagnosis Market Share by Type in 2018

    • Figure China Non-invasive Cancer Diagnosis Market Share by Type in 2023

    • Figure China Non-invasive Cancer Diagnosis Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Clinical Chemistry (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Molecular Diagnostics (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Production Volume and Growth Rate of Immunochemistry/Immunoassay (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Market Share by Application in 2018

    • Figure China Non-invasive Cancer Diagnosis Market Share by Application in 2023

    • Figure China Non-invasive Cancer Diagnosis Total Market Size and Growth Rate from Consumption End

    • Figure China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Solid Tumors (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Blood Cancer (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Market Size and Growth Rate of Others (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Production Volume by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Production Volume Share by Region (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Production Volume Share by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Production Value by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Production Value Share by Region (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Production Value Share by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Sales Volume by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Sales Volume Share by Region (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Sales Volume Share by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Sales Value by Region (2018-2023)

    • Table China Non-invasive Cancer Diagnosis Sales Value Share by Region (2018-2023)

    • Figure China Non-invasive Cancer Diagnosis Sales Value Share by Region (2018-2023)

    • Table North China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table North China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure North China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table North China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table North China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure North China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table Central China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table Central China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure Central China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table Central China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table Central China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure Central China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table South China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table South China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure South China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table South China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table South China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure South China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table East China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table East China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure East China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table East China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table East China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure East China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table Northeast China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table Northeast China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure Northeast China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table Northeast China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table Northeast China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table Southwest China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table Southwest China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure Southwest China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table Southwest China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table Southwest China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table Northwest China Non-invasive Cancer Diagnosis Production Volume by Type (2018-2023)

    • Table Northwest China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Figure Northwest China Non-invasive Cancer Diagnosis Production Volume Share by Type (2018-2023)

    • Table Northwest China Non-invasive Cancer Diagnosis Sales Volume by Application (2018-2023)

    • Table Northwest China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Non-invasive Cancer Diagnosis Sales Volume Share by Application (2018-2023)

    • Table BioView Inc Company Profile

    • Table BioView Inc Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table Gen-Probe Inc Company Profile

    • Table Gen-Probe Inc Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table A&G Pharmaceutical Company Profile

    • Table A&G Pharmaceutical Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table LabCorp Company Profile

    • Table LabCorp Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table Digene Corporation Company Profile

    • Table Digene Corporation Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table Affymetrix Inc Company Profile

    • Table Affymetrix Inc Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table Quest Diagnostics Inc Company Profile

    • Table Quest Diagnostics Inc Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)

    • Table Precision Therapeutics Company Profile

    • Table Precision Therapeutics Non-invasive Cancer Diagnosis Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US